Moreover, mismatch repair deficient IDH-mutant astrocytomas are characterized by worse outcomes [4], and CDKN2A/B deletions may occur together with other copy number alterations in oligodendroglioma, defining the distinct subgroup of oligosarcomas linked to short survival [5]. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).